MannKind Corp (MNKD) stock
MNKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30273% above fair value
$4.13−0.03 (-0.72%)
Close on Nov 13, 2026Market cap $1.33BP/E –Yield –
MannKind total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
MannKind's total debt was $121.83M at Sep 30, 2020. For fiscal 2019 it was $118.90M.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $118.90M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2020 | Sep 30, 2020 | $121.83M | – |
| Q4 FY2019 | Dec 31, 2019 | $118.90M | – |
See a number that looks wrong?